ProShare Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-12,797
| Closed | -$872K | – | 1916 |
|
|
2022
Q3 | $872K | Buy |
12,797
+728
| +6% | +$40.1K | ﹤0.01% | 757 |
|
|
2022
Q2 | $386K | Sell |
12,069
-6,255
| -34% | -$183K | ﹤0.01% | 1073 |
|
|
2022
Q1 | $634K | Sell |
18,324
-4,285
| -19% | -$128K | ﹤0.01% | 1139 |
|
|
2021
Q4 | $662K | Buy |
22,609
+1,603
| +8% | +$49.7K | ﹤0.01% | 1273 |
|
|
2021
Q3 | $535K | Sell |
21,006
-5,708
| -21% | -$168K | ﹤0.01% | 1172 |
|
|
2021
Q2 | $936K | Buy |
26,714
+18,114
| +211% | +$707K | ﹤0.01% | 1077 |
|
|
2021
Q1 | $350K | Sell |
8,600
-937
| -10% | -$43.1K | ﹤0.01% | 1697 |
|
|
2020
Q4 | $413K | Sell |
9,537
-352
| -4% | -$17.4K | ﹤0.01% | 1392 |
|
|
2020
Q3 | $545K | Buy |
9,889
+153
| +2% | +$9.72K | ﹤0.01% | 910 |
|
|
2020
Q2 | $615K | Sell |
9,736
-1,946
| -17% | -$133K | ﹤0.01% | 863 |
|
|
2020
Q1 | $597K | Sell |
11,682
-9,195
| -44% | -$616K | ﹤0.01% | 696 |
|
|
2019
Q4 | $1.66M | Sell |
20,877
-1,968
| -9% | -$117K | 0.01% | 659 |
|
|
2019
Q3 | $1.11M | Buy |
22,845
+711
| +3% | +$37.1K | 0.01% | 717 |
|
|
2019
Q2 | $1.16M | Sell |
22,134
-2,821
| -11% | -$162K | 0.01% | 710 |
|
|
2019
Q1 | $1.32M | Buy |
24,955
+1,987
| +9% | +$97.6K | 0.01% | 694 |
|
|
2018
Q4 | $943K | Sell |
22,968
-4,374
| -16% | -$164K | 0.01% | 724 |
|
|
2018
Q3 | $1.04M | Sell |
27,342
-1,018
| -4% | -$45.1K | 0.01% | 807 |
|
|
2018
Q2 | $1.28M | Buy |
28,360
+1,620
| +6% | +$73.8K | 0.01% | 746 |
|
|
2018
Q1 | $1.29M | Sell |
26,740
-2,283
| -8% | -$127K | 0.01% | 740 |
|
|
2017
Q4 | $1.14M | Buy |
29,023
+1,836
| +7% | +$68.6K | 0.01% | 776 |
|
|
2017
Q3 | $844K | Buy |
27,187
+1,538
| +6% | +$43.3K | 0.01% | 774 |
|
|
2017
Q2 | $702K | Buy |
25,649
+3,827
| +18% | +$114K | 0.01% | 838 |
|
|
2017
Q1 | $804K | Sell |
21,822
-5,490
| -20% | -$138K | 0.01% | 827 |
|
|
2016
Q4 | $395K | Buy |
+27,312
| New | +$480K | ﹤0.01% | 1209 |
|
Other funds holding GBT
ProShare Advisors's GBT Position: Q4 2022 in Review
ProShare Advisors sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 12,797 shares — an estimated $872K sold.
ProShare Advisors first reported a position in GBT in Q4 2016 and held it in 24 quarters. The position peaked at $1.66M in Q4 2019. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- ProShare Advisors reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- ProShare Advisors sold 12,797 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $872K.
- ProShare Advisors first reported a position in Global Blood Therapeutics, Inc. in Q4 2016 and held it in 24 quarters.
- ProShare Advisors's Global Blood Therapeutics, Inc. position peaked at $1.66M in Q4 2019.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on ProShare Advisors's 13F filing for Q4 2022, filed 2 Feb 2023.